PortfoliosLab logo

Avenue Therapeutics, Inc. (ATXI)

Equity · Currency in USD · Last updated Mar 18, 2023

Share Price Chart

Loading data...


The chart shows the growth of $10,000 invested in Avenue Therapeutics, Inc. in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $90 for a total return of roughly -99.10%. All prices are adjusted for splits and dividends.

ATXI (Avenue Therapeutics, Inc.)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with ATXI

Avenue Therapeutics, Inc.


Avenue Therapeutics, Inc. had a return of -4.31% year-to-date (YTD) and -88.91% in the last 12 months. Over the past 10 years, Avenue Therapeutics, Inc. had an annualized return of -56.17%, while the S&P 500 had an annualized return of 8.80%, indicating that Avenue Therapeutics, Inc. did not perform as well as the benchmark.

1 month-7.50%-5.31%
6 months-72.28%0.39%
1 year-88.91%-10.12%
5 years (annualized)-57.94%7.32%
10 years (annualized)-56.17%8.80%

Monthly Returns Heatmap


Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Avenue Therapeutics, Inc. Sharpe ratio is -0.39. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.

ATXI (Avenue Therapeutics, Inc.)
Benchmark (^GSPC)

Dividend History

Avenue Therapeutics, Inc. doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.

ATXI (Avenue Therapeutics, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the Avenue Therapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Avenue Therapeutics, Inc. is 99.43%, recorded on Mar 8, 2023. The portfolio has not recovered from it yet.



To Bottom


To Recover



-99.43%Sep 15, 2020624Mar 8, 2023
-74.55%Jun 28, 2017325Oct 10, 2018304Dec 26, 2019629
-43.11%Feb 11, 202026Mar 18, 202050May 29, 202076
-18.31%Jun 1, 202030Jul 13, 202026Aug 18, 202056
-11.46%Jan 2, 202010Jan 15, 20208Jan 28, 202018
-7.42%Aug 21, 20205Aug 27, 202011Sep 14, 202016
-4.24%Jan 29, 20202Jan 30, 20202Feb 3, 20204
-2.29%Feb 5, 20201Feb 5, 20201Feb 6, 20202

Volatility Chart

Current Avenue Therapeutics, Inc. volatility is 110.17%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.

ATXI (Avenue Therapeutics, Inc.)
Benchmark (^GSPC)